Tag: inflammation

The delicate balance of hormonal health in men has taken a significant turn as new research indicates that both excessively low and abnormally high levels of testosterone are linked to a heightened risk of atrial fibrillation (AF). According to a comprehensive review of existing evidence published in the Journal of the Endocrine Society, the relationship…

New clinical research presented at the ENDO 2026 annual meeting has revealed a significant and potentially practice-changing correlation between the use of semaglutide and a reduced incidence of bone fractures in patients diagnosed with type 2 diabetes. The study, led by researchers from the Stanford University Medical Center, suggests that despite the substantial weight loss…

The American Medical Association (AMA) House of Delegates (HOD) convened its Annual Meeting in Chicago this past June, bringing together a vast assembly of physicians, residents, and medical students to deliberate on the most pressing issues facing the modern healthcare landscape. Among the primary participants in this legislative process were representatives from the Endocrine Society,…

A comprehensive analysis of real-world data has challenged the long-held assumption that significant weight loss automatically translates to a more active lifestyle. The study, presented at the ENDO 2026 annual meeting, indicates that individuals utilizing Glucagon-like peptide-1 (GLP-1) receptor agonists—a class of drugs including blockbuster medications like semaglutide and tirzepatide—tended to log fewer daily steps…

The annual ENDO conference, the flagship meeting of the Endocrine Society, serves as the premier global stage for the dissemination of cutting-edge research in hormone health and metabolic medicine. Among its most anticipated sessions is the Rising Star Power Talks, a high-stakes, "blitz-style" competition designed to provide early-career investigators and in-training members with a national…

The Endocrine Society is intensifying its long-standing advocacy efforts by joining a broad coalition of the scientific community to call for a significant increase in federal investment for the National Institutes of Health (NIH). On September 17, a delegation of specialized researchers and physician-scientists from the Society will arrive in Washington, D.C., to participate in…

The clinical landscape for managing type 2 diabetes and obesity has been fundamentally altered by the advent of glucagon-like peptide-1 (GLP-1) receptor agonists, yet new data suggests that patient adherence to these regimens is far more volatile than previously understood. Research presented at the ENDO 2026 annual meeting indicates that while GLP-1 medications are highly…

The landscape of endocrinology research is undergoing a transformative shift as the demand for higher sensitivity, greater throughput, and uncompromising accuracy reaches unprecedented levels. In an era where hormonal imbalances and metabolic disorders are becoming increasingly prevalent worldwide, the scientific community is leaning on sophisticated laboratory technologies to bridge the gap between theoretical research and…

A groundbreaking study published in the journal Endocrinology has shed new light on the critical windows of thyroid hormone influence during early development. Led by Karine Gauthier, PhD, at the L’Institut de Génomique Fonctionnelle de Lyon in France, the research reveals that the timing of thyroid hormone deficiency is a decisive factor in determining long-term…

On July 15, a landmark coalition of 38 professional medical organizations, patient advocacy groups, and research institutions formally endorsed the National Strategy to Close the Women’s Health Gap, a comprehensive policy framework designed to address systemic inequities in the American healthcare system. Led by the Society for Women’s Health Research (SWHR), the American College of…